HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db07-1742v1 57/6/1745    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Harries, L. W. Articles by Hattersley, A. T. PubMed PubMed Citation Articles by Harries, L. W. Articles by Hattersley, A. T. Related Collections Related Article Social Bookmarking                What's this?

The Diabetic Phenotype in HNF4A Mutation Carriers Is Moderated By the Expression of HNF4A Isoforms From the P1 Promoter During Fetal Development

¹ Institute of Biomedical and Clinical Sciences, Peninsula Medical School, Exeter, U.K
² Centre for Human Development, Stem Cells & Regeneration, Human Genetics Division, University of Southampton, Southampton, U.K
³ Department of Clinical Medicine, University of Bergen, Bergen, Norway
⁴ Department of Paediatrics, Haukeland University Hospital, Bergen, Norway

Corresponding author: L.W. Harries, Institute of Biomedical and Clinical Sciences, Peninsula Medical School, Barrack Road, Exeter, U.K. E-mail: l.w.harries{at}exeter.ac.uk

Abbreviations: AF, activation function; β2M, β-2-microglobulin; Ct, crossing point; HNF, hepatocyte nuclear factor; MODY, maturity-onset diabetes of the young

OBJECTIVE—Mutations in the alternatively spliced HNF4A gene cause maturity-onset diabetes of the young (MODY). We characterized the spatial and developmental expression patterns of HNF4A transcripts in human tissues and investigated their role as potential moderators of the MODY phenotype.

RESEARCH DESIGN AND METHODS—We measured the expression of HNF4A isoforms in human adult tissues and gestationally staged fetal pancreas by isoform-specific real-time PCR. The correlation between mutation position and age of diagnosis or age-related penetrance was assessed in a cohort of 190 patients with HNF4A mutations.

RESULTS—HNF4A was expressed exclusively from the P2 promoter in adult pancreas, but from 9 weeks until at least 26 weeks after conception, up to 23% of expression in fetal pancreas was of P1 origin. HNF4A4–6 transcripts were not detected in any tissue. In whole pancreas, HNF4A9 expression was greater than in islets isolated from the endocrine pancreas (relative level 22 vs. 7%). Patients with mutations in exons 9 and 10 (absent from HNF4A3, HNF4A6, and HNF4A9 isoforms) developed diabetes later than those with mutations in exons 2–8, where all isoforms were affected (40 vs. 24 years; P = 0.029). Exon 9/10 mutations were also associated with a reduced age-related penetrance (53 vs. 10% without diabetes at age 55 years; P < 0.00001).

CONCLUSIONS—We conclude that isoforms derived from the HNF4A P1 promoter are expressed in human fetal, but not adult, pancreas, and that their presence during pancreatic development may moderate the diabetic phenotype in individuals with mutations in the HNF4A gene.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

HNF4A and Diabetes: Injury Before Insult?

Ben Z. Stanger
Diabetes 2008 57: 1461-1462. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				B. Z. Stanger HNF4A and Diabetes: Injury Before Insult? Diabetes, June 1, 2008; 57(6): 1461 - 1462. [Full Text] [PDF]